High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated

BACKGROUND: Despite being the most common pelvic gynecologic malignancy in industrialized countries, no targeted therapies are available for patients with metastatic endometrial carcinoma. In order to improve treatment, underlying molecular characteristics of primary and metastatic disease must be e...

Descripción completa

Detalles Bibliográficos
Autores principales: Krakstad, Camilla, Birkeland, Even, Seidel, Danila, Kusonmano, Kanthida, Petersen, Kjell, Mjøs, Siv, Hoivik, Erling A., Wik, Elisabeth, Halle, Mari Kyllesø, Øyan, Anne M., Kalland, Karl-Henning, Werner, Henrica Maria Johanna, Trovik, Jone, Salvesen, Helga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531332/
https://www.ncbi.nlm.nih.gov/pubmed/23300780
http://dx.doi.org/10.1371/journal.pone.0052795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531332/
https://www.ncbi.nlm.nih.gov/pubmed/23300780
http://dx.doi.org/10.1371/journal.pone.0052795

Ejemplares similares